Cargando…

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity

PURPOSE: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife(®) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to evaluate the prognostic factors for local control...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibault, Jean-Emmanuel, Dewas, Sylvain, Vautravers-Dewas, Claire, Hollebecque, Antoine, Jarraya, Hajer, Lacornerie, Thomas, Lartigau, Eric, Mirabel, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795696/
https://www.ncbi.nlm.nih.gov/pubmed/24147002
http://dx.doi.org/10.1371/journal.pone.0077472
_version_ 1782287415835099136
author Bibault, Jean-Emmanuel
Dewas, Sylvain
Vautravers-Dewas, Claire
Hollebecque, Antoine
Jarraya, Hajer
Lacornerie, Thomas
Lartigau, Eric
Mirabel, Xavier
author_facet Bibault, Jean-Emmanuel
Dewas, Sylvain
Vautravers-Dewas, Claire
Hollebecque, Antoine
Jarraya, Hajer
Lacornerie, Thomas
Lartigau, Eric
Mirabel, Xavier
author_sort Bibault, Jean-Emmanuel
collection PubMed
description PURPOSE: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife(®) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to evaluate the prognostic factors for local control and overall survival following this treatment. PATIENTS AND METHODS: 75 patients with 96 liver-confined HCC were treated with SBRT at the Oscar Lambret Comprehensive Cancer Center. Fiducials were implanted in the liver before treatment and were used as markers to track the lesion’s movement. Treatment response was scored according to RECIST v1.1. Local control and overall survival were calculated using the Kaplan and Meier method. A stepwise multivariate analysis (Cox regression) of prognostic factors was performed for local control and overall survival. RESULTS: There were 67 patients with Child-Turcotte-Pugh (CTP) Class A and eight patients with CTP Class B. Treatment was administered in three sessions. A total dose of 40–45 Gy to the 80% isodose line was delivered. The median follow-up was 10 months (range, 3–49 months). The local control rate was 89.8% at 1 and 2 years. Overall survival was 78.5% and 50.4% at 1 and 2 years, respectively. Toxicity mainly consisted of grade 1 and grade 2 events. Higher alpha-fetoprotein (aFP) levels were associated with less favorable local control (HR=1.001; 95% CI [1.000, 1.002]; p=0.0063). A higher dose was associated with better local control (HR=0.866; 95% CI [0.753, 0.996]; p=0.0441). A Child-Pugh score higher than 5 was associated with worse overall survival (HR= 3.413; 95% CI [1.235, 9.435]; p=0.018). CONCLUSION: SBRT affords good local tumor control and higher overall survival rates than other historical controls (best supportive care or sorafenib). High aFP levels were associated with lesser local control, but a higher treatment dose improved local control.
format Online
Article
Text
id pubmed-3795696
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37956962013-10-21 Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity Bibault, Jean-Emmanuel Dewas, Sylvain Vautravers-Dewas, Claire Hollebecque, Antoine Jarraya, Hajer Lacornerie, Thomas Lartigau, Eric Mirabel, Xavier PLoS One Research Article PURPOSE: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife(®) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to evaluate the prognostic factors for local control and overall survival following this treatment. PATIENTS AND METHODS: 75 patients with 96 liver-confined HCC were treated with SBRT at the Oscar Lambret Comprehensive Cancer Center. Fiducials were implanted in the liver before treatment and were used as markers to track the lesion’s movement. Treatment response was scored according to RECIST v1.1. Local control and overall survival were calculated using the Kaplan and Meier method. A stepwise multivariate analysis (Cox regression) of prognostic factors was performed for local control and overall survival. RESULTS: There were 67 patients with Child-Turcotte-Pugh (CTP) Class A and eight patients with CTP Class B. Treatment was administered in three sessions. A total dose of 40–45 Gy to the 80% isodose line was delivered. The median follow-up was 10 months (range, 3–49 months). The local control rate was 89.8% at 1 and 2 years. Overall survival was 78.5% and 50.4% at 1 and 2 years, respectively. Toxicity mainly consisted of grade 1 and grade 2 events. Higher alpha-fetoprotein (aFP) levels were associated with less favorable local control (HR=1.001; 95% CI [1.000, 1.002]; p=0.0063). A higher dose was associated with better local control (HR=0.866; 95% CI [0.753, 0.996]; p=0.0441). A Child-Pugh score higher than 5 was associated with worse overall survival (HR= 3.413; 95% CI [1.235, 9.435]; p=0.018). CONCLUSION: SBRT affords good local tumor control and higher overall survival rates than other historical controls (best supportive care or sorafenib). High aFP levels were associated with lesser local control, but a higher treatment dose improved local control. Public Library of Science 2013-10-11 /pmc/articles/PMC3795696/ /pubmed/24147002 http://dx.doi.org/10.1371/journal.pone.0077472 Text en © 2013 Bibault et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bibault, Jean-Emmanuel
Dewas, Sylvain
Vautravers-Dewas, Claire
Hollebecque, Antoine
Jarraya, Hajer
Lacornerie, Thomas
Lartigau, Eric
Mirabel, Xavier
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
title Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
title_full Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
title_fullStr Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
title_full_unstemmed Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
title_short Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
title_sort stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795696/
https://www.ncbi.nlm.nih.gov/pubmed/24147002
http://dx.doi.org/10.1371/journal.pone.0077472
work_keys_str_mv AT bibaultjeanemmanuel stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT dewassylvain stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT vautraversdewasclaire stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT hollebecqueantoine stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT jarrayahajer stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT lacorneriethomas stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT lartigaueric stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity
AT mirabelxavier stereotacticbodyradiationtherapyforhepatocellularcarcinomaprognosticfactorsoflocalcontroloverallsurvivalandtoxicity